Similar articles

• Effect of antihypertensive therapy on left ventricular hypertrophy in essential hypertension.

  Frohlich ED. Frohlich ED. Adv Nephrol Necker Hosp. 1990;19:87-100. Adv Nephrol Necker Hosp. 1990. PMID: 1967894 Review. No abstract available.
• Favourable haemodynamic effects of a new multifactorial antihypertensive on left ventricular dimension, wall thickness and function in hypertensive patients.

  Sheiban I, Arosio E, Tonni S, Montresor G, Priante F, Lechi A. Sheiban I, et al. Eur Heart J. 1992 Jun;13 Suppl A:37-44. doi: 10.1093/eurheartj/13.suppl_a.37. Eur Heart J. 1992. PMID: 1356775 Clinical Trial. No abstract available.
• A novel therapeutic approach for reversal of left ventricular hypertrophy and blood pressure control in hypertensive patients treated with alpha-methyldopa or propranolol.

  Fernandez PG, Snedden W, Kim BK, Lee CC. Fernandez PG, et al. Can J Physiol Pharmacol. 1985 Apr;63(4):304-8. doi: 10.1139/y85-055. Can J Physiol Pharmacol. 1985. PMID: 3159468 Clinical Trial.
• Effect on atrial natriuretic peptides of chronic treatment with alpha-methyldopa and hydralazine in spontaneously hypertensive rats.

  Kohno M, Yasunari K, Murakawa K, Yokokawa K, Horio T, Kurihara N, Takeda T. Kohno M, et al. Am J Hypertens. 1990 Feb;3(2):111-6. doi: 10.1093/ajh/3.2.111. Am J Hypertens. 1990. PMID: 2137701
• [Possibilities of reverse development of left-ventricular hypertrophy in hypertension].

  Bakhshaliev AB, Akhmetzianova EKh, Gadzhiev RF, Teboeva RV. Bakhshaliev AB, et al. Klin Med (Mosk). 1989 Mar;67(3):10-7. Klin Med (Mosk). 1989. PMID: 2526273 Review. Russian. No abstract available.